Review article: the overlap between functional dyspepsia and irritable bowel syndrome a tale of one or two disorders

被引:52
作者
Cremonini, F [1 ]
Talley, NJ [1 ]
机构
[1] Mayo Clin, Coll Med, CENTER Program, Rochester, MN 55905 USA
关键词
D O I
10.1111/j.1365-2036.2004.02184.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Functional dyspepsia and irritable bowel syndrome are currently considered to be two separate nosological entities. However, the overlap of symptoms and the evidence of a number of common pathophysiological characteristics suggest that functional dyspepsia and irritable bowel syndrome may be different presentations of the same disorder. In this review, we critically appraise points in common, as well as differences, in the epidemiology, pathophysiology and response to treatment of functional dyspepsia and irritable bowel syndrome. Population-based studies and large case series show that one- to two-thirds of subjects with irritable bowel syndrome have symptoms that overlap with functional dyspepsia. Symptom analyses have generally failed to support functional dyspepsia and irritable bowel syndrome as separate entities. An exaggerated motor response to meals, delayed gastric emptying and abnormal small bowel and colonic transit can all be found in subsets of functional dyspepsia and irritable bowel syndrome, and are not exclusive to either condition. Visceral hypersensitivity is a common feature to both entities and seems unlikely to be site or disease specific. There is good evidence for the post-infectious development of irritable bowel syndrome, and this may also apply in functional dyspepsia. Psychiatric comorbidities are similar in functional dyspepsia and irritable bowel syndrome. Several common drug classes (prokinetics, visceral analgesics, psychoactive agents) may similarly improve both functional dyspepsia and irritable bowel syndrome symptoms. The evidence available suggests that at least subsets of functional dyspepsia and irritable bowel syndrome represent different manifestations of a single entity. The identification of common pathophysiological targets for therapy should be pursued in future research.
引用
收藏
页码:40 / 49
页数:10
相关论文
共 84 条
[1]   IRRITABLE-BOWEL-SYNDROME AND DYSPEPSIA IN THE GENERAL-POPULATION - OVERLAP AND LACK OF STABILITY OVER TIME [J].
AGREUS, L ;
SVARDSUDD, K ;
NYREN, O ;
TIBBLIN, G .
GASTROENTEROLOGY, 1995, 109 (03) :671-680
[2]  
Agréus L, 2001, AM J GASTROENTEROL, V96, P2905
[3]   Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice [J].
Barbara, G ;
Vallance, BA ;
Collins, SM .
GASTROENTEROLOGY, 1997, 113 (04) :1224-1232
[4]   Whole gut transit scintigraphy in the clinical evaluation of patients with upper and lower gastrointestinal symptoms [J].
Bonapace, ES ;
Maurer, AH ;
Davidoff, S ;
Krevsky, B ;
Fisher, RS ;
Parkman, HP .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (10) :2838-2847
[5]   Rectal distention testing in patients with irritable bowel syndrome:: Sensitivity, specificity, and predictive values of pain sensory thresholds [J].
Bouin, M ;
Plourde, V ;
Boivin, M ;
Riberdy, M ;
Lupien, F ;
Laganière, M ;
Verrier, P ;
Poitras, P .
GASTROENTEROLOGY, 2002, 122 (07) :1771-1777
[6]   Dyspepsia [J].
Bytzer, P ;
Talley, NJ .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (09) :815-822
[7]   Management of the irritable bowel syndrome [J].
Camilleri, M .
GASTROENTEROLOGY, 2001, 120 (03) :652-668
[8]   Irritable bowel syndrome [J].
Camilleri, M ;
Choi, MG .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (01) :3-15
[9]   Drugs targeting functional bowel disorders: lessons from drug trials [J].
Camilleri, M .
CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (06) :684-690
[10]   Functional dyspepsia, upper gastrointestinal symptoms, and transit in children [J].
Chitkara, DK ;
Delgado-Aros, S ;
Bredenoord, AJ ;
Cremonini, F ;
El-Youssef, M ;
Frffsf, D ;
Camilleri, M .
JOURNAL OF PEDIATRICS, 2003, 143 (05) :609-613